Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Kling

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Lab Animal|September 10, 2020
The basics of biocontainmentJim Kling
Lab Animal|December 8, 2020
CRISPR gets crunchyJim Kling
Nature Biotechnology|December 11, 2007
Biotech for your companion?Jim Kling
Nature Biotechnology|September 12, 2012
Patient powerJim Kling
Nature Biotechnology|February 10, 2012
Fresh from the biotech pipeline--2011 [corrected]Jim Kling
Nature Biotechnology|April 10, 2010
Safety signal dampens reception for mipomersen antisenseJim Kling
Science (New York, N.Y.)|March 4, 2006
Careers in systems biology. Working the systemsJim Kling
Nature Biotechnology|July 15, 2006
Merck moves into biotechJim Kling
Nature Biotechnology|May 9, 2012
Hypoxia-activated prodrugs forge ahead in cancerJim Kling
EMBO Reports|November 3, 2005
Where the future went. In response to market trends and patenting laws, genomics companies are adapting their strategiesJim Kling
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Lab Animal|September 10, 2020
The basics of biocontainmentJim Kling
Lab Animal|December 8, 2020
CRISPR gets crunchyJim Kling
Nature Biotechnology|December 11, 2007
Biotech for your companion?Jim Kling
Nature Biotechnology|September 12, 2012
Patient powerJim Kling
Nature Biotechnology|February 10, 2012
Fresh from the biotech pipeline--2011 [corrected]Jim Kling
Nature Biotechnology|April 10, 2010
Safety signal dampens reception for mipomersen antisenseJim Kling
Science (New York, N.Y.)|March 4, 2006
Careers in systems biology. Working the systemsJim Kling
Nature Biotechnology|July 15, 2006
Merck moves into biotechJim Kling
Nature Biotechnology|May 9, 2012
Hypoxia-activated prodrugs forge ahead in cancerJim Kling
EMBO Reports|November 3, 2005
Where the future went. In response to market trends and patenting laws, genomics companies are adapting their strategiesJim Kling
Pageof 6